查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1625252

2030 年生醫光電市場預測：按技術、應用、最終用戶和地區進行的全球分析

Biophotonics Market Forecasts to 2030 - Global Analysis By Technology (In-vivo and In-vitro), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC的數據，2024年全球生醫光電市場規模為760.8億美元，預計在預測期內將以12.2%的複合年成長率成長，到2030年達到1517.9億美元。

生醫光電是生物學和醫學中基於光的技術的研究和應用。光用於理解和操縱細胞、組織和器官等生物系統。這個跨學科領域結合了物理學、生物學和工程學的原理，發展出影像、診斷、治療和治療的工具。螢光顯微鏡、光學相干斷層掃描和雷射治療等技術在生醫光電中很常見，促進了醫學影像、疾病檢測和標靶治療等領域的進步。

政府支持和資金籌措

政府機構的資助通常會加速新生醫光電技術的開發，並實現醫學診斷、影像和治療方面的突破。津貼、補貼和稅收優惠鼓勵私人公司投資生醫光電並降低與開發新技術相關的財務風險。此外，公共資金支持大學、研究機構和產業領導者之間的合作，以加速生醫光電產品的商業化。旨在推動醫療保健和醫療設備的政府舉措將進一步推動臨床和實驗室環境中生醫光電應用的需求。這種全面的支援不僅推動市場成長，還確保最尖端科技融入主流醫療保健解決方案。

技術限制

將光電與生物系統整合非常複雜，並對準確性和可靠性提出了挑戰。先進生醫光電技術的高成本限制了其在研究和臨床應用中的應用。設備之間缺乏標準化和互通性阻礙了與現有醫療保健基礎設施的無縫整合。此外，影像系統有限的靈敏度和解析度妨礙了準確的診斷和治療監測。最後，操作生醫光電工具所需的專門訓練和專業知識也是廣泛使用的障礙。

擴大再生醫學的應用

在組織再生中使用基於光的技術，例如基於雷射的治療和成像技術，正在提高治療的精度和有效性。生醫光電可以更好地可視化和監測細胞過程，這對於開發新的再生療法至關重要。隨著幹細胞研究和基因治療的進步，生醫光電工具對於追蹤細胞行為和組織再生至關重要。對非侵入性診斷工具的需求也促進了再生醫學中生醫光電的發展。隨著再生醫學的不斷發展，生醫光電在實現突破性治療和改善患者治療效果方面發揮關鍵作用。

隱私和資料安全問題

透過生醫光電應用產生的醫療資料高度敏感，引發了對未授權存取和濫用的擔憂。 GDPR 等嚴格法規要求生醫光電公司在安全系統上投入大量資金，增加了營運成本。資料保護措施不足可能會導致資訊洩露，損害公司的聲譽和信譽。消費者不願共用個人健康資訊將進一步減緩生醫光電技術的採用。因此，這些擔憂正在減緩創新生醫光電解決方案在醫療診斷和治療中的採用。

COVID-19 的影響

COVID-19 大流行對生醫光電市場產生了重大影響，擾亂了製造、供應鏈和研究活動。然而，生醫光電在醫療保健領域的採用，特別是診斷和治療應用，也在加速。對快速、非侵入性測試（例如 COVID-19 檢測和監測）的需求不斷成長，推動了光學生物感測器和成像系統的創新。儘管早期遭遇挫折，但隨著全球醫療保健技術投資的增加，這場大流行凸顯了生醫光電在醫療診斷中的重要性，並提振了該行業的長期成長前景。

預計體內細分市場在預測期內將是最大的

透過實現生物過程的即時成像和監測，體內領域有望實現利潤豐厚的成長。組織、細胞和器官的非侵入性高解析度視覺化提高了診斷準確性和治療監測。對個人化醫療和早期疾病檢測日益成長的需求進一步推動了體內生醫光電的採用。此外，其在藥物發現和臨床前測試中的應用提高了藥物開發的效率和成功率，成為市場發展的驅動力。隨著研究投資的增加和醫療保健領域的進步，體內領域繼續塑造生醫光電市場的未來。

預計醫療領域在預測期內複合年成長率最高

由於先進的診斷和治療方法，預計醫療治療領域在預測期內將出現最高的複合年成長率。生醫光電促進了光學相干斷層掃描 (OCT) 等非侵入性成像技術，以增強疾病檢測和監測。生醫光電也支持標靶治療並提高癌症和其他疾病的治療精度。此外，雷射技術的創新可以實現更有效的手術和更短的恢復時間。隨著醫療保健需求的發展，醫療產業對生醫光電學來改善患者照護的依賴不斷擴大，刺激了市場成長。

比最大的地區

由於醫療保健、農業和環境領域的進步，預計亞太地區在預測期內將佔據最大的市場佔有率。對影像和光譜等診斷技術的需求不斷成長，加上慢性病盛行率的上升，正在推動市場的發展。該地區的生物技術和醫療設備產業進一步推動了生醫光電的需求。中國、日本和印度等國家正大力投資研發，以促進治療和診斷應用的創新。

複合年成長率最高的地區：

由於醫療診斷、治療和研究應用的進步，預計北美在預測期內將出現最高的複合年成長率。關鍵技術包括光學相干斷層掃描（OCT）、螢光成像和拉曼光譜，廣泛應用於癌症檢測、藥物傳輸、組織分析等領域。該地區受益於強大的醫療基礎設施、大量的研發投資以及對非侵入性診斷技術的高需求。美國和加拿大的領先公司正在投資創新解決方案以推動成長。政府的舉措，加上醫療保健意識的提高，正在進一步推動北美市場的擴張。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球生醫光電市場：依技術分類

  • 體內
  • 試管內

第6章全球生醫光電市場：依應用分類

  • 透視成像
  • 內部影像
  • 光譜分子
  • 表面成像
  • 顯微鏡檢查
  • 光療
  • 分析感測
  • 生物感測器
  • 其他用途

第7章全球生醫光電市場：依最終用戶分類

  • 醫學診斷
  • 治療
  • 測試和組件
  • 非醫療用途
  • 其他最終用戶

第8章全球生醫光電市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、合作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章 公司概況

  • Thermo Fisher Scientific Inc.
  • Carl Zeiss AG
  • Horiba Ltd.
  • Olympus Corporation
  • Abcam Plc
  • Biolitec AG
  • Agilent Technologies Inc.
  • Sartorius AG
  • Lumenis Ltd.
  • PerkinElmer Inc.
  • LightLab Imaging, Inc.
  • Medtronic Plc
  • Photonis Technologies
  • Nikon Corporation
  • Beckman Coulter, Inc.
Product Code: SMRC28207

According to Stratistics MRC, the Global Biophotonics Market is accounted for $76.08 billion in 2024 and is expected to reach $151.79 billion by 2030 growing at a CAGR of 12.2% during the forecast period. Biophotonics is the study and application of light-based technologies in biological and medical sciences. It involves using light to understand and manipulate biological systems, such as cells, tissues, and organs. This interdisciplinary field combines principles from physics, biology, and engineering to develop tools for imaging, diagnosis, therapy, and treatment. Techniques like fluorescence microscopy, optical coherence tomography, and laser-based therapies are common in biophotonics, enabling advancements in areas such as medical imaging, disease detection, and targeted treatments.

Market Dynamics:

Driver:

Government support and funding

Financial backing from government agencies often accelerates the development of new biophotonic technologies, enabling breakthroughs in medical diagnostics, imaging, and therapy. Grants, subsidies, and tax incentives encourage private companies to invest in biophotonics, reducing the financial risks associated with developing novel technologies. Additionally, public funding supports collaborations between universities, research institutions, and industry leaders, facilitating the commercialization of biophotonic products. Government initiatives aimed at advancing healthcare and medical devices further drive demand for biophotonic applications in clinical and laboratory settings. This collective support not only stimulates market growth but also ensures the integration of cutting-edge technologies into mainstream healthcare solutions.

Restraint:

Technical limitations

Complexities in integrating photonics with biological systems create challenges in precision and reliability. High costs associated with advanced biophotonics technologies restrict their widespread adoption in research and clinical applications. The lack of standardization and interoperability between devices hampers seamless integration into existing healthcare infrastructures. Additionally, limitations in the sensitivity and resolution of imaging systems prevent accurate diagnostics and therapeutic monitoring. Finally, the need for specialized training and expertise to operate biophotonics tools adds another barrier to widespread implementation.

Opportunity:

Expanding applications in regenerative medicine

The use of light-based technologies in tissue regeneration, such as laser-based therapies and imaging techniques, is enhancing the precision and effectiveness of medical treatments. Biophotonics enables better visualization and monitoring of cellular processes, which is critical in developing new regenerative therapies. With advances in stem cell research and gene therapy, biophotonics tools are essential for tracking cellular behavior and tissue regeneration. The demand for non-invasive diagnostic tools also contributes to the growth of biophotonics in regenerative medicine. As regenerative medicine continues to evolve, biophotonics plays a crucial role in enabling groundbreaking therapies and improving patient outcomes.

Threat:

Privacy and data security concerns

The sensitive nature of medical data generated through biophotonics applications raises fears of unauthorized access and misuse. Stringent regulations, such as GDPR, require biophotonics companies to invest heavily in secure systems, adding to operational costs. Inadequate data protection measures can lead to potential breaches, harming a company's reputation and credibility. Consumer reluctance to share personal health information further slows adoption of biophotonics technologies. Consequently, these concerns delay the widespread implementation of innovative biophotonics solutions in medical diagnostics and treatment.

Covid-19 Impact

The Covid-19 pandemic significantly impacted the biophotonics market, with disruptions in manufacturing, supply chains, and research activities. However, it also accelerated the adoption of biophotonics in healthcare, particularly for diagnostic and therapeutic applications. Increased demand for rapid, non-invasive testing, such as for Covid-19 detection and monitoring, drove innovations in optical biosensors and imaging systems. Despite initial setbacks, the pandemic highlighted the importance of biophotonics in medical diagnostics, boosting long-term growth prospects in the sector as investment in healthcare technologies increased globally.

The in-vivo segment is expected to be the largest during the forecast period

The in-vivo segment is estimated to have a lucrative growth, by enabling real-time imaging and monitoring of biological processes. It allows for non-invasive, high-resolution visualization of tissues, cells, and organs, enhancing diagnostic accuracy and treatment monitoring. The growing demand for personalized medicine and early disease detection further fuels the adoption of in-vivo biophotonics. Additionally, its applications in drug discovery and pre-clinical studies drive market growth by improving the efficiency and success rates of pharmaceutical developments. With increasing research investments and healthcare advancements, the in-vivo segment continues to shape the future of the Biophotonics market.

The medical therapeutic segment is expected to have the highest CAGR during the forecast period

The medical therapeutic segment is anticipated to witness the highest CAGR growth during the forecast period, due to advanced diagnostic and treatment methods. It facilitates non-invasive imaging techniques, such as optical coherence tomography (OCT), which enhances disease detection and monitoring. Biophotonics also supports targeted therapies, improving the precision of treatments for conditions like cancer. Additionally, innovations in laser technologies allow for more effective surgeries with faster recovery times. As healthcare demands evolve, the medical sector's reliance on biophotonics for improved patient care continues to expand, stimulating market growth.

Region with largest share:

Asia Pacific is expected to hold the largest market share during the forecast period by advancements in healthcare, agriculture, and environmental sectors. Increasing demand for diagnostic technologies, such as imaging and spectroscopy, coupled with the rising prevalence of chronic diseases, is propelling the market. The region's booming biotechnology and medical device industries further contribute to the demand for biophotonics. Countries like China, Japan, and India are at the forefront, with substantial investments in research and development, fostering innovation in therapeutic and diagnostic applications.

Region with highest CAGR:

North America is expected to have the highest CAGR over the forecast period, owing to advancements in medical diagnostics, therapeutics, and research applications. Key technologies include optical coherence tomography (OCT), fluorescence imaging, and Raman spectroscopy, widely used in cancer detection, drug delivery, and tissue analysis. The region benefits from a robust healthcare infrastructure, substantial investments in research and development, and a high demand for non-invasive diagnostic techniques. Leading players in the U.S. and Canada are investing in innovative solutions, fostering growth. Government initiatives, coupled with increasing healthcare awareness, further support the market's expansion in North America.

Key players in the market

Some of the key players profiled in the Biophotonics Market include Thermo Fisher Scientific Inc., Carl Zeiss AG, Horiba Ltd., Olympus Corporation, Abcam Plc, Biolitec AG, Agilent Technologies Inc., Sartorius AG, Lumenis Ltd., PerkinElmer Inc. and LightLab Imaging, Inc.

Key Developments:

In November 2024, Carl Zeiss Meditec AG entered a strategic partnership with the Singapore Eye Research Institute (SERI). This collaboration focuses on improving surgical outcomes in refractive and cataract surgeries, with a funding commitment under Singapore's Research, Innovation and Enterprise.

In January 2024, Thermo Fisher announced a strategic collaboration with Galapagos NV for decentralized CAR-T manufacturing in the San Francisco area. This agreement includes providing GMP manufacturing and logistics services for Galapagos' CAR-T clinical program, marking a significant step in expanding their decentralized manufacturing strategy.

In July 2023, Carl Zeiss entered a long-term strategic partnership with the European Molecular Biology Laboratory (EMBL). This collaboration is focused on advancing research in molecular biology through innovative imaging technologies.

Technologies Covered:

  • In-vivo
  • In-vitro

Applications Covered:

  • See-through Imaging
  • Inside Imaging
  • Spectro Molecular
  • Surface Imaging
  • Microscopy
  • Light Therapy
  • Analytical Sensing
  • Biosensors
  • Other Applications

End Users Covered:

  • Medical Diagnostics
  • Medical Therapeutic
  • Tests & Components
  • Nonmedical Application
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biophotonics Market, By Technology

  • 5.1 Introduction
  • 5.2 In-vivo
  • 5.3 In-vitro

6 Global Biophotonics Market, By Application

  • 6.1 Introduction
  • 6.2 See-through Imaging
  • 6.3 Inside Imaging
  • 6.4 Spectro Molecular
  • 6.5 Surface Imaging
  • 6.6 Microscopy
  • 6.6 Light Therapy
  • 6.8 Analytical Sensing
  • 6.9 Biosensors
  • 6.10 Other Applications

7 Global Biophotonics Market, By End User

  • 7.1 Introduction
  • 7.2 Medical Diagnostics
  • 7.3 Medical Therapeutic
  • 7.4 Tests & Components
  • 7.5 Nonmedical Application
  • 7.6 Other End Users

8 Global Biophotonics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Thermo Fisher Scientific Inc.
  • 10.2 Carl Zeiss AG
  • 10.3 Horiba Ltd.
  • 10.4 Olympus Corporation
  • 10.5 Abcam Plc
  • 10.6 Biolitec AG
  • 10.7 Agilent Technologies Inc.
  • 10.8 Sartorius AG
  • 10.9 Lumenis Ltd.
  • 10.10 PerkinElmer Inc.
  • 10.11 LightLab Imaging, Inc.
  • 10.12 Medtronic Plc
  • 10.13 Photonis Technologies
  • 10.14 Nikon Corporation
  • 10.15 Beckman Coulter, Inc.

List of Tables

  • Table 1 Global Biophotonics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 3 Global Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
  • Table 4 Global Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
  • Table 5 Global Biophotonics Market Outlook, By Application (2022-2030) ($MN)
  • Table 6 Global Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
  • Table 7 Global Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
  • Table 8 Global Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
  • Table 9 Global Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
  • Table 10 Global Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
  • Table 11 Global Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
  • Table 12 Global Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
  • Table 13 Global Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
  • Table 14 Global Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 15 Global Biophotonics Market Outlook, By End User (2022-2030) ($MN)
  • Table 16 Global Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
  • Table 17 Global Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
  • Table 18 Global Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
  • Table 19 Global Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
  • Table 20 Global Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 21 North America Biophotonics Market Outlook, By Country (2022-2030) ($MN)
  • Table 22 North America Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 23 North America Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
  • Table 24 North America Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
  • Table 25 North America Biophotonics Market Outlook, By Application (2022-2030) ($MN)
  • Table 26 North America Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
  • Table 27 North America Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
  • Table 28 North America Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
  • Table 29 North America Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
  • Table 30 North America Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
  • Table 31 North America Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
  • Table 32 North America Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
  • Table 33 North America Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
  • Table 34 North America Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 35 North America Biophotonics Market Outlook, By End User (2022-2030) ($MN)
  • Table 36 North America Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
  • Table 37 North America Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
  • Table 38 North America Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
  • Table 39 North America Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
  • Table 40 North America Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 41 Europe Biophotonics Market Outlook, By Country (2022-2030) ($MN)
  • Table 42 Europe Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 43 Europe Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
  • Table 44 Europe Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
  • Table 45 Europe Biophotonics Market Outlook, By Application (2022-2030) ($MN)
  • Table 46 Europe Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
  • Table 47 Europe Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
  • Table 48 Europe Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
  • Table 49 Europe Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
  • Table 50 Europe Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
  • Table 51 Europe Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
  • Table 52 Europe Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
  • Table 53 Europe Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
  • Table 54 Europe Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 55 Europe Biophotonics Market Outlook, By End User (2022-2030) ($MN)
  • Table 56 Europe Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
  • Table 57 Europe Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
  • Table 58 Europe Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
  • Table 59 Europe Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
  • Table 60 Europe Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 61 Asia Pacific Biophotonics Market Outlook, By Country (2022-2030) ($MN)
  • Table 62 Asia Pacific Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 63 Asia Pacific Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
  • Table 64 Asia Pacific Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
  • Table 65 Asia Pacific Biophotonics Market Outlook, By Application (2022-2030) ($MN)
  • Table 66 Asia Pacific Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
  • Table 67 Asia Pacific Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
  • Table 68 Asia Pacific Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
  • Table 69 Asia Pacific Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
  • Table 70 Asia Pacific Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
  • Table 71 Asia Pacific Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
  • Table 72 Asia Pacific Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
  • Table 73 Asia Pacific Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
  • Table 74 Asia Pacific Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 75 Asia Pacific Biophotonics Market Outlook, By End User (2022-2030) ($MN)
  • Table 76 Asia Pacific Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
  • Table 77 Asia Pacific Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
  • Table 78 Asia Pacific Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
  • Table 79 Asia Pacific Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
  • Table 80 Asia Pacific Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 81 South America Biophotonics Market Outlook, By Country (2022-2030) ($MN)
  • Table 82 South America Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 83 South America Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
  • Table 84 South America Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
  • Table 85 South America Biophotonics Market Outlook, By Application (2022-2030) ($MN)
  • Table 86 South America Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
  • Table 87 South America Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
  • Table 88 South America Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
  • Table 89 South America Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
  • Table 90 South America Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
  • Table 91 South America Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
  • Table 92 South America Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
  • Table 93 South America Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
  • Table 94 South America Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 95 South America Biophotonics Market Outlook, By End User (2022-2030) ($MN)
  • Table 96 South America Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
  • Table 97 South America Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
  • Table 98 South America Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
  • Table 99 South America Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
  • Table 100 South America Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 101 Middle East & Africa Biophotonics Market Outlook, By Country (2022-2030) ($MN)
  • Table 102 Middle East & Africa Biophotonics Market Outlook, By Technology (2022-2030) ($MN)
  • Table 103 Middle East & Africa Biophotonics Market Outlook, By In-vivo (2022-2030) ($MN)
  • Table 104 Middle East & Africa Biophotonics Market Outlook, By In-vitro (2022-2030) ($MN)
  • Table 105 Middle East & Africa Biophotonics Market Outlook, By Application (2022-2030) ($MN)
  • Table 106 Middle East & Africa Biophotonics Market Outlook, By See-through Imaging (2022-2030) ($MN)
  • Table 107 Middle East & Africa Biophotonics Market Outlook, By Inside Imaging (2022-2030) ($MN)
  • Table 108 Middle East & Africa Biophotonics Market Outlook, By Spectro Molecular (2022-2030) ($MN)
  • Table 109 Middle East & Africa Biophotonics Market Outlook, By Surface Imaging (2022-2030) ($MN)
  • Table 110 Middle East & Africa Biophotonics Market Outlook, By Microscopy (2022-2030) ($MN)
  • Table 111 Middle East & Africa Biophotonics Market Outlook, By Light Therapy (2022-2030) ($MN)
  • Table 112 Middle East & Africa Biophotonics Market Outlook, By Analytical Sensing (2022-2030) ($MN)
  • Table 113 Middle East & Africa Biophotonics Market Outlook, By Biosensors (2022-2030) ($MN)
  • Table 114 Middle East & Africa Biophotonics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 115 Middle East & Africa Biophotonics Market Outlook, By End User (2022-2030) ($MN)
  • Table 116 Middle East & Africa Biophotonics Market Outlook, By Medical Diagnostics (2022-2030) ($MN)
  • Table 117 Middle East & Africa Biophotonics Market Outlook, By Medical Therapeutic (2022-2030) ($MN)
  • Table 118 Middle East & Africa Biophotonics Market Outlook, By Tests & Components (2022-2030) ($MN)
  • Table 119 Middle East & Africa Biophotonics Market Outlook, By Nonmedical Application (2022-2030) ($MN)
  • Table 120 Middle East & Africa Biophotonics Market Outlook, By Other End Users (2022-2030) ($MN)